期刊文献+

非布司他对高尿酸血症患者炎性因子的影响及疗效观察 被引量:3

下载PDF
导出
摘要 目的观察非布司他对高尿酸血症患者炎性因子的影响及疗效。方法选取医院收治的高尿酸血症患者120例为研究对象,随机分为对照组和观察组,每组60例。2组患者均给予常规治疗,对照组给予苯溴马隆片治疗,观察组给予非布司他治疗,观察2组治疗后炎性因子的变化及临床疗效。结果观察组治疗总有效率为95.0%,高于对照组的80.0%(P<0.05)。治疗后,2组炎性因子水平较治疗前均降低,且观察组炎性因子水平低于对照组(P<0.05)。2组患者在治疗过程中均未出现严重不良反应。结论非布司他定治疗高尿酸血症对患者的炎性因子具有显著性影响,可有效改善临床疗效,值得推广应用。
出处 《临床合理用药杂志》 2017年第14期43-44,共2页 Chinese Journal of Clinical Rational Drug Use
  • 相关文献

参考文献5

二级参考文献50

  • 1FILIOPOULOS V, HADJIYANNAKOS D, VLASSOPOULOSD. New insights into uric acid effects on the progression andprognosis of chronic kidney disease [J]. Ren Fail,2012,34(4):510-520.
  • 2WEINER DE, TIGHIOUART H,ELSAYED E F, et al. Uricacid and incident kidney disease in the community [J], J AmSoc Nephrol,2008,19 (6) : 1204-1211.
  • 3TERKELTAUB R, BUSHIUSKY DA, BECKER MA. Recentdevelopments in our understanding of the renal basis ofhyperuricemia and the development of novel antihyperuricemictherapeutics [J], Arthritis Res Ther, 2006, 8 (suppl) : S4.
  • 4CHAO J, TERKELTAUB R. A critical reappraisal ofallopurinol dosing, safety, and efficacy for hyperuricemia ingout [J]. Rheumato Rep, 2009,11 (2) : 135-140.
  • 5TAYAR JH, LOPEZ - OLIV 0 MA, Suarez - Almazor. Febuxostatfor treating chronic gout [J]. Cochrane Database Syst Rev,2012,14 (1):11.
  • 6ISEKI K, IKEMIYA Y,INOUE T, et al. Significance ofhyperuricemia as a risk factor for developing ESRD in ascreened cohort [J]. Am J Kidney Dis,2004,44(4) :642-650.
  • 7CHONCHOL M, SHLIPAK MG, KATZ R, et al. Relationshipof uric acid with progression of kidney disease [J]. Am JKidney Dis ,2007, 50 (2) :239-247.
  • 8SIU YP, LEUNG KT, TONG MK, et al. Use of allopurinol inslowing the progression of renal disease through its ability tolower serum uric acid level [ J ]. Am J Kidney Dis,2006,47?1):51-59.
  • 9SHIBAGAKI Y, OHNO I’ HOSOYA T, et al. Safety,efficacy and renal effect of febuxostat in patients withmoderate -to - severe kidney dysfunction [J]. Hypertens Res,2014,37(10):919-925.
  • 10SIRCAR D,CHATTERJEE S,WAIKHOM H, et al. Efficacyof Febuxostat for Slowing the GFR Decline in Patients WithCKD and Asymptomatic Hyperuricemia : A 6-Month, Double-Blind, Randomized, Placebo - Controlled Trial [J].Am JKidney Dis, 2015,66(6) :945-950.

共引文献121

同被引文献20

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部